Evidence map›Paper›PMID 38737428›Full record

ArticleOpen forum infectious diseases2024

No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.

Mirinda Ann Gormley, Phillip Moschella, Susan Cordero-Romero, Wesley R Wampler, Marie Allison, Katiey Kitzmiller, Luke Estes, Moonseong Heo, Alain H Litwin, Prerana Roth

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mirinda Ann GormleyDepartment of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.ORCID https://orcid.org/0000-0002-8158-7055
Phillip MoschellaDepartment of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.ORCID https://orcid.org/0000-0001-7299-4997
Susan Cordero-RomeroDepartment of Emergency Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.ORCID https://orcid.org/0009-0001-9081-8580
Wesley R WamplerDepartment of Ambulance Services, Prisma Health Upstate, Greenville, South Carolina, USA.ORCID https://orcid.org/0000-0002-7993-4898
Marie AllisonDepartment of Internal Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
Katiey KitzmillerDepartment of Internal Medicine, Prisma Health Upstate, Greenville, South Carolina, USA.
Luke EstesDepartment of Ambulance Services, Prisma Health Upstate, Greenville, South Carolina, USA.
Moonseong HeoDepartment of Public Health Sciences, Clemson University, Clemson, South Carolina, USA.ORCID https://orcid.org/0000-0001-7711-1209
Alain H LitwinSchool of Health Research, Clemson University, Clemson, South Carolina, USA.ORCID https://orcid.org/0000-0002-6717-0288
Prerana RothSchool of Health Research, Clemson University, Clemson, South Carolina, USA.ORCID https://orcid.org/0000-0002-3923-7051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study evaluates a novel multidisciplinary program providing expanded access to hepatitis C virus (HCV) treatment for rural Appalachian patients in South Carolina. This program identified patients via an opt-out emergency department screening program, and it aimed to achieve HCV cure by using community paramedics (CPs) to link and monitor patients from treatment initiation through 12-week sustained virologic response (SVR). Methods: Patients aged ≥18 years who were HCV RNA positive were eligible for enrollment if they failed to appear for a scheduled HCV appointment or reported barriers to accessing office-based treatment. CPs provided home visits (initial and 4, 12, and 24 weeks) using a mobile Wi-Fi hotspot to support telemedicine appointments (compliant with the Health Insurance Portability and Accountability Act) and perform focused physical assessments, venipuncture, and coordinated home delivery of medications. Statistics described participant characteristics, prevalence of SVR, and patient satisfaction results at 12 weeks posttreatment. Results: Thirty-four patients were eligible for SVR laboratory tests by 31 August 2023; the majority were male (61.7%) and White (64.7%) with an average age of 56 years (SD, 11.7). Twenty-eight (82.4%) completed treatment and achieved 12-week SVR. Six (17.6%) were lost to follow-up. Two-thirds strongly agreed that they were satisfied with the overall care that they received, and half strongly agreed that their overall health had improved. Conclusions: This CP-augmented treatment program demonstrated success curing HCV for rural patients who lacked access to office-based treatment. Other health care systems may consider this novel delivery model to treat hard-to-reach individuals who are HCV positive.

Indexed as

community paramedicineHCVHCV treatmentruraltelemedicine

Identifiers

PMID38737428
PMCPMC11088356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.